2026 NPPES data Neurology Physician NPI 1578649224 M.D.
Verify on CMS →

ANDREW ROSE-INNES, M.D.

Neurology Physician in PORTLAND, Oregon. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
607
Medicare Part D claims · 145 beneficiaries · Neurology Physician avg: 1K
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
86.0353/100
▲ 3 pts above national avg 83.1 · [object Object]

What the federal data shows

ANDREW ROSE-INNES, M.D. reported a CMS MIPS final score of 86.0353/100 — above the 83.1 national average — and filed 607 Medicare Part D claims in 2023.

86.0353/100
MIPS score · +3 vs avg
607
Part D claims, 2023
89%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ANDREW ROSE-INNES, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

86 Top 48% higher than 52% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ANDREW ROSE-INNES, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 5 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ANDREW ROSE-INNES, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 10/27/2006

NPI 1578649224

Primary specialty

Neurology Physician

Mid-sized

19,866 US NPIs in this specialty

Medicare Part D claims

607 54% vs specialty avg

2023 prescription claims

Specialty avg: 1,309

MIPS final score

86.0353/100 2.9353000000000122% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Oregon

How Neurology Physician compares to other specialties among Oregon providers

Oregon providers

Neurology Physician share within Oregon

1. Neurology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neurology Physician share within Oregon

Medicare quality performance — MIPS

ANDREW ROSE-INNES, M.D.'s 2023 MIPS final score plotted against the Neurology Physician national average

High performer (top quartile)
MIPS Final Score
86.0353/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Neurology Physician) — 86.0353/100 vs national avg 83.1

0%100%National avg83%86%
MIPS final score (Neurology Physician) — 86.0353/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANDREW ROSE-INNES, M.D. appears in the CMS NPPES registry as a Neurology Physician provider holding M.D. credentials at 1040 NW 22ND AVE, PORTLAND, OR, 97210, with a listed phone of (503) 488-2424. NPI 1578649224 was issued on 10/27/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ROSE-INNES most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 607 prescription claims written by this provider, covering 145 Medicare beneficiaries and totaling roughly $149K in drug spend, split 11% brand-name and 89% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 86.0353/100 for the 2023 performance year (Quality 77.8032, Cost 74.1514), compared with the national average of 83.1.

Neurology Physician is a mid-sized specialty nationwide, with 19,866 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1040 NW 22ND AVE
PORTLAND, OR 97210

Provider Details

NPI 1578649224
Specialty Neurology Physician
Credentials M.D.
Gender Male
NPI Issued 10/27/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

86.0353
Final Score
Avg: 83.1
77.8032
Quality
74.1514
Cost
99
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where ANDREW ROSE-INNES, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PIEDMONT ATHENS HOSPITALIST PHYSICIANS LLC
ATHENS, GA
PORTLAND CLINIC
PORTLAND, OR
UPSON MEDICAL ASSOCIATES LLC
PORTLAND, OR
VIRTUAL NEUROLOGY LLC
PORTLAND, OR
VIRTUAL NEUROLOGY TEXAS PLLC
PORTLAND, OR

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

ANDREW ROSE-INNES, M.D. — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 607 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

607
Total Claims
$149K
Total Drug Cost
145
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,050
Total Day Supply
30,487
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$85K
Generic Drug Cost
$64K

Patient Demographics

Average Patient Age
69.2 years
Avg HCC Risk Score
1.38
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ANDREW ROSE-INNES, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Gabapentin
102
Levetiracetam
42
Baclofen
28
Clonazepam
28
Memantine Hcl
24
Carbidopa-Levodopa
Carbidopa/Levodopa
22
Nortriptyline Hcl
22
Primidone
22
Aimovig Autoinjector
Erenumab-Aooe
20
Pyridostigmine Bromide
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurology Physician Overview

How ANDREW ROSE-INNES, M.D. fits within the Neurology Physician landscape nationally.

19,866
Neurology Physician Providers in US
54
States with Neurology Physician
1,309
Avg Claims per Provider

ANDREW ROSE-INNES, M.D.'s 607 claims are below the specialty average of 1,309.

Nearby Neurology Physician Providers in Oregon

Other clinicians with the same primary specialty enrolled in Oregon, drawn from the same CMS NPPES roster as ROSE-INNES.

Compare Neurology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANDREW ROSE-INNES, M.D.'s specialty?
ANDREW ROSE-INNES, M.D. specializes in Neurology Physician and practices in PORTLAND, Oregon. Credentials: M.D..
How much does ANDREW ROSE-INNES, M.D. prescribe under Medicare Part D?
In 2023, ANDREW ROSE-INNES, M.D. wrote 607 Medicare Part D claims totaling $149K in drug costs for 145 beneficiaries.
What is ANDREW ROSE-INNES, M.D.'s Medicare quality score?
ANDREW ROSE-INNES, M.D. has a CMS MIPS Final Score of 86.0353/100 (Quality: 77.8032, Cost: 74.1514). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ANDREW ROSE-INNES, M.D. located?
ANDREW ROSE-INNES, M.D. is located at 1040 NW 22ND AVE, PORTLAND, OR, 97210. Phone: (503) 488-2424.
What is ANDREW ROSE-INNES, M.D.'s NPI number?
ANDREW ROSE-INNES, M.D.'s National Provider Identifier (NPI) is 1578649224, issued on 10/27/2006.
Does ANDREW ROSE-INNES, M.D. prescribe more brand-name or generic drugs?
ANDREW ROSE-INNES, M.D.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $85K in brand drug costs.
How many Neurology Physician providers are there in the US?
There are 19,866 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,309 Medicare Part D claims per year.
What drugs does ANDREW ROSE-INNES, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ANDREW ROSE-INNES, M.D.'s most frequently prescribed drugs include Gabapentin, Levetiracetam, Baclofen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANDREW ROSE-INNES, M.D. accept Medicare?
ANDREW ROSE-INNES, M.D. appears in CMS Medicare data with 607 Part D claims and 145 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANDREW ROSE-INNES, M.D.'s credentials?
ANDREW ROSE-INNES, M.D.'s NPI is 1578649224 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology